Literature DB >> 7945162

Deterioration in myocardial blood flow following relief of sustained ischemia is not associated with release of endothelin into the coronary sinus.

K Przyklenk1, B Z Simkhovich, B Bauer, R A Kloner.   

Abstract

Numerous studies have described a progressive deterioration in resting myocardial blood flow following relief of sustained ischemia in both necrotic and salvaged myocardium (termed "no reflow" and "low reflow", respectively). We sought to determine whether release of the potent vasoconstrictor peptide endothelin-1 may play a role in these phenomena. As part of a previous study in our laboratory, 14 anesthetized open-chest dogs underwent 1 h of coronary artery occlusion and 4 h of reperfusion, while 2 dogs served as time-matched sham-operated controls (artery isolated but not occluded). Regional myocardial blood flow was measured by injection of radiolabeled microspheres at 30 min and 4 h post reflow; endothelin-1 concentrations in the coronary sinus were determined by radioimmunoassay at baseline, during coronary occlusion and at 30 min and 4 h after reperfusion; and the extent of myocardial necrosis was delineated by post-mortem tetrazolium staining. As expected, in dogs subjected to ischemia/reperfusion, regional myocardial blood flow deteriorated between 30 min and 4 h post reflow in both the subendocardium (1.40 +/- 0.30 versus 0.48 +/- 0.06 ml/min/g; p = 0.003; reflecting a mixture of no reflow and low reflow) and subepicardium (0.84 +/- 0.08 versus 0.64 +/- 0.07 ml/min/g; p = 0.03; due to low reflow). However, endothelin levels showed only a modest and nonsignificant increase during the protocol (4.1 +/- 0.5, 4.7 +/- 0.2 and 4.9 +/- 0.6 pg/ml plasma at baseline, 30 min and 4 h post reflow; p = NS), and regression analysis revealed no correlation between release of endothelin and deterioration in blood flow in either myocardial layer. Moreover, the sham-operated controls showed a similar modest increase in endothelin levels, with no change in myocardial perfusion during the course of the protocol. We therefore conclude that deterioration in myocardial blood flow following relief of sustained ischemia in the anesthetized open-chest dog is not associated with release of endothelin-1 into the coronary sinus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7945162     DOI: 10.1007/bf00795618

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  24 in total

1.  Endothelin release during ischaemia and reperfusion of isolated perfused rat hearts.

Authors:  F Brunner; E F du Toit; L H Opie
Journal:  J Mol Cell Cardiol       Date:  1992-11       Impact factor: 5.000

2.  Increased plasma endothelin-1 in the early hours of acute myocardial infarction.

Authors:  D J Stewart; G Kubac; K B Costello; P Cernacek
Journal:  J Am Coll Cardiol       Date:  1991-07       Impact factor: 24.094

3.  Progressive failure of coronary flow during reperfusion of myocardial infarction: documentation of the no reflow phenomenon with positron emission tomography.

Authors:  R W Jeremy; J M Links; L C Becker
Journal:  J Am Coll Cardiol       Date:  1990-09       Impact factor: 24.094

4.  Does preconditioning protect the coronary vasculature from subsequent ischemia/reperfusion injury?

Authors:  B Bauer; B Z Simkhovich; R A Kloner; K Przyklenk
Journal:  Circulation       Date:  1993-08       Impact factor: 29.690

5.  Plasma endothelin-1 in acute myocardial infarction with heart failure.

Authors:  H Tomoda
Journal:  Am Heart J       Date:  1993-03       Impact factor: 4.749

6.  Endothelin-1 in patients with complicated and uncomplicated myocardial infarction.

Authors:  P Lechleitner; N Genser; J Mair; J Maier; E Artner-Dworzak; F Dienstl; B Puschendorf
Journal:  Clin Investig       Date:  1992-12

7.  Influence of endothelin on cardiovascular function, oxygen free radicals, and blood chemistry.

Authors:  K Prasad; P Lee; J Kalra
Journal:  Am Heart J       Date:  1991-01       Impact factor: 4.749

8.  Plasma endothelin-1 concentrations in the coronary sinus in dogs with artificially induced myocardial infarction.

Authors:  T Miyauchi; T Doi; N Suzuki; M Kakihana; I Yamaguchi; Y Sugishita; T Mitsui; M Hori; T Masaki; K Goto
Journal:  Peptides       Date:  1992 Sep-Oct       Impact factor: 3.750

9.  Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog.

Authors:  R L Engler; G W Schmid-Schönbein; R S Pavelec
Journal:  Am J Pathol       Date:  1983-04       Impact factor: 4.307

10.  The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

Authors:  R A Kloner; C E Ganote; R B Jennings
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.